Rocket Lab

Rocket Lab's Neutron Rocket Development Update: Testing Failure, Schedule to be Discussed in Q4 Earnings Call.

RocketLabUSA

Rocket Lab's 15min chart: Bollinger Bands Narrowing, KDJ Death Cross detected.

Goldman Sachs

Goldman Sachs Raises Rocket Lab PT to $69, Maintains Neutral Rating

Rocket Lab's 15min chart triggered RSI Oversold, KDJ Golden Cross signal.

Kratos Defense & Security Solutions

Mercury Systems

AST SpaceMobile

Bannix Acquisition

Pentagon Awards $151 Billion Contract Ceiling for Golden Dome Missile Defense Architecture

Catalyst<ul> <li>Most analysts rate RKLB Buy or Strong Buy, showing broad institutional optimism.</li></ul>Risk<ul> <li>Technical indicators show that the market is in a volatile state, and the direction is not clear enough.</li> <li>Bearish signals are obviously dominant (2 bearish vs 0 bullish).</li> <li>Fund flows show negative net inflow across all order size buckets.</li></ul>

Key Factors

Morgan Stanley upgraded Rocket Lab (RKLB) to Overweight with a $105 price target, the highest on the street, citing its strategic position in the growing space technology sector. RKLB's stock surged 6.1% to an all-time high following the upgrade but later plunged 6.1% intraday amid profit-taking and valuation concerns. Rocket Lab secured a $816 million contract with the SDA and achieved record Q3 revenue of $155 million, signaling strong operational momentum. BofA Securities maintained a Buy rating for RKLB with a $120 price target, while Goldman Sachs raised its price target to $69, maintaining a Neutral rating. The Pentagon's $151 billion Golden Dome missile defense initiative positions RKLB for potential growth in the expanding defense and space markets.

Recent Updates

RKLB News